Oct 14, 2019 / 08:30PM GMT
Operator
Good afternoon, everyone, and thank you for joining us for this conference call discussing Aytu BioScience's announced acquisition of a six-product commercial portfolio. With me this afternoon to discuss the details of the acquisition is Aytu's Chairman and Chief Executive Officer, Josh Disbrow.
Aytu BioScience issued a press release this morning announcing the acquisition with details describing the transaction. A copy of the press release is available on the news page of the Company's website at aytubio.com.
I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the press release. In addition, a webcast will be accessible live and archived on Aytu BioScience's website within the investors section under events and presentations at aytubio.com.
Finally, I'd also like to call your attention to the customary Safe Harbor disclosure regarding forward-looking information. The conference call today will contain certain forward-looking statements, including statements
Aytu BioScience Inc Acquires Prescription Product Portfolio from Cerecor Inc - M&A Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot